1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsLung Vascular Biology Program is sponsored by National Heart, Lung, and Blood Institute (NHLBI). Supports research on pulmonary vascular biology, including conditions like portal hypertension.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Latest Funding Opportunity Announcements (FOAs) Single Source: HeartShare 2. 0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Data Translation Center (U54 Clinical Trial Optional) HeartShare 2.
0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Clinical Trial Center and Clinical Centers (U01 Clinical Trial Optional) Single Source: Cardiothoracic Surgical Trials Network (CTSN) Data Coordinating Center (U01 Clinical Trial Required) Looking for a contact in your research area? Select a topic within the sections below to find a program officer and funding related to that topic.
Research Opportunity Announcement (ROA) OTA-21-015I: RECOVER PASC IMMUNOPHENOTYPING CORE LABORATORIES Research Opportunity Announcement (ROA) for Clinical Trials for the Prevention and/or Treatment of Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Notice of Intent to Publish a Research Opportunity Announcement (ROA) for Clinical Trials for the Prevention and/or Treatment of Post-Acute Sequelae of SARS CoV2 infection (PASC) (ROA): Observational Studies of COVID-19 – A Cohort of Cohorts OTA-2-011A Advanced Technologies and Surgery Adult and Pediatric Cardiac Research Atherothrombosis and Coronary Artery Disease Basic and Early Translational Research Clinical Applications and Prevention Global Cardiovascular Research Heart Failure & Arrhythmias Heart Development & Structural Diseases Heart Failure Data Challenge Office of Clinical Research Prevention and Population Sciences Vascular Biology and Hypertension Acute Lung Injury/Critical Care Chronic Obstructive Pulmonary Disease (COPD)/Environment Genetics, Genomics, and Advanced Technologies Interstitial Lung Disease/Fibrosis Lung Developmental Biology/Neonatal and Pediatric Diseases Lung Response to Pulmonary Infections, Microbiome, AIDS and Tuberculosis Sleep Science and Sleep Disorders Blood Epidemiology and Clinical Therapeutics Molecular Cellular and Systems Blood Science Translational Blood Science and Resources Sleep Science and Sleep Disorders Implementation Science Research Health Inequities and Global Health Precision Medicine Activities (TOPMed) (ROA): BioData Catalyst Data Management Core Program OTA-21-018 Clinical Trials Optimization Clinical Trials Optimization (Early Phase, Multi-Site, Single-Site, Late Phase) Global Cardiovascular Research
According to the current listing, eligibility includes: Nonprofits, For-profits, Universities, State/local governments, Small businesses, Individuals. Confirm the full requirements in the official notice before applying.
Lung Vascular Biology Program is funded by National Heart, Lung, and Blood Institute (NHLBI). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articleThe $46M FSHARP program is creating shelf-stable synthetic blood from freeze-dried components. A new SWiFT SBIR topic opened May 6 for autonomous field transfusion devices. What grant seekers in biomedical engineering need to know.
Read articleDARPA MTO opened six FY26 SBIR topics on May 27 with a June 24 deadline — nanopore proteomics, compact RF filters, 800°C ICs, passive thermal spreaders, radiation-hardened codesign, and low-resource computing. The topics read like a wishlist for the next decade of contested-environment microelectronics. Here is what each one is actually asking for, and how small businesses should triage the four-week window.
Read article